Subcutaneous implantable cardioverter-defibrillator therapy in Poland: Results of the Polish S-ICD Registry.
Kempa M, Budrejko S, Tajstra M, Syska P, Lewandowski M, Fabiszak T, Michalak M, Stanek A, Nowak K, Mitkowski P, Kaczmarek K, Orski Z, Janowski M, Szafarz P, Filipecki A, Sokal A, Szołkiewicz M, Jagielski D, Przybylski A.
Kardiol Pol. 2023;81(5):455-462. doi: 10.33963/KP.a2023.0046. Epub 2023 Mar 5.
The extravascular implantable cardioverter-defibrillator: characterization of anatomical parameters impacting substernal implantation and defibrillation efficacy.
Molnár L, Crozier I, Haqqani H, O'Donnell D, Kotschet E, Alison J, Thompson AE, Bhatia VA, Papp R, Zima E, Jermendy Á, Apor A, Merkely B.
Europace. 2022 May 3;24(5):762-773. doi: 10.1093/europace/euab243.
Meta-Analysis of Clinical Outcome After Implantable Cardioverter-Defibrillator Implantation in Patients With Brugada Syndrome.
Dereci A, Yap SC, Schinkel AFL.
JACC Clin Electrophysiol. 2019 Feb;5(2):141-148. doi: 10.1016/j.jacep.2018.09.005. Epub 2018 Nov 1.
Implantation of Implantable Cardioverter Defibrillators in Kazakhstan.
Begisbayev T, Kosherbayeva L, Akhmetov V, Khvan D, Brimzhanova M.
Glob Heart. 2022 May 10;17(1):30. doi: 10.5334/gh.1119. eCollection 2022.
Upgrade from implantable cardioverter-defibrillator vs. de novo implantation of cardiac resynchronization therapy: long-term outcomes.
Jędrzejczyk-Patej E, Mazurek M, Kotalczyk A, Kowalska W, Konieczny-Kozielska A, Kozielski J, Podolecki T, Szulik M, Sokal A, Kowalski O, Kalarus Z, Średniawa B, Lenarczyk R.
Europace. 2021 Jan 27;23(1):113-122. doi: 10.1093/europace/euaa339.
The implantable cardioverter-defibrillator: An update.
Miller JD, Yousuf O, Berger RD.
Trends Cardiovasc Med. 2015 Oct;25(7):606-11. doi: 10.1016/j.tcm.2015.01.015. Epub 2015 Feb 7.
Characterization of the PRAETORIAN score in Japanese patients undergoing subcutaneous implantable cardioverter-defibrillator implantation.
Yamazaki K, Ishida Y, Sasaki S, Toyama Y, Nishizaki K, Kinjo T, Itoh T, Kimura M, Sakai S, Shikanai S, Sorimachi Y, Hamaura S, Tomita H.
J Cardiol. 2022 Nov;80(5):482-486. doi: 10.1016/j.jjcc.2022.06.014. Epub 2022 Jul 25.
Outcomes of subcutaneous implantable cardioverter-defibrillator implantation in patients on hemodialysis.
Koman E, Gupta A, Subzposh F, Saltzman H, Kutalek SP.
J Interv Card Electrophysiol. 2016 Mar;45(2):219-23. doi: 10.1007/s10840-015-0093-2. Epub 2016 Jan 14.
Performance of an implantable cardioverter-defibrillator lead family.
Klampfleitner S, Mundel M, Schinke K, Neuberger HR.
J Cardiovasc Electrophysiol. 2023 Mar;34(3):700-709. doi: 10.1111/jce.15804. Epub 2023 Jan 22.
Evaluating current implantable cardioverter defibrillator implantation procedures: can common complications be minimised?
Timmers L, Van Heuverswyn F, De Wilde H, Jordaens L.
Expert Rev Cardiovasc Ther. 2016;14(5):579-89. doi: 10.1586/14779072.2016.1144471. Epub 2016 Feb 10.
